Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-19-007896
Filing Date
2019-08-09
Accepted
2019-08-09 16:02:46
Documents
66
Period of Report
2019-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q ampe-20190630x10q.htm 10-Q 1595938
2 EX-31.1 ampe-20190630ex3114e00c2.htm EX-31.1 18899
3 EX-31.2 ampe-20190630ex312f04a3c.htm EX-31.2 18761
4 EX-32.1 ampe-20190630ex3210a42aa.htm EX-32.1 10077
5 GRAPHIC ampe20190630x10q001.jpg GRAPHIC 4975
  Complete submission text file 0001558370-19-007896.txt   6336704

Data Files

Seq Description Document Type Size
6 EX-101.INS ampe-20190630.xml EX-101.INS 1504842
7 EX-101.SCH ampe-20190630.xsd EX-101.SCH 45352
8 EX-101.CAL ampe-20190630_cal.xml EX-101.CAL 30776
9 EX-101.DEF ampe-20190630_def.xml EX-101.DEF 151551
10 EX-101.LAB ampe-20190630_lab.xml EX-101.LAB 334461
11 EX-101.PRE ampe-20190630_pre.xml EX-101.PRE 293856
Mailing Address 373 INVERNESS PARKWAY SUITE 200 ENGLEWOOD CO 80112
Business Address 373 INVERNESS PARKWAY SUITE 200 ENGLEWOOD CO 80112 720-437-6500
Ampio Pharmaceuticals, Inc. (Filer) CIK: 0001411906 (see all company filings)

EIN.: 260179592 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35182 | Film No.: 191012953
SIC: 2834 Pharmaceutical Preparations